0 334

Cited 29 times in

The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance

DC Field Value Language
dc.contributor.author김상운-
dc.contributor.author김성훈-
dc.contributor.author김영태-
dc.contributor.author김재욱-
dc.contributor.author김재훈-
dc.contributor.author남은지-
dc.contributor.author윤보성-
dc.contributor.author조남훈-
dc.date.accessioned2014-12-21T16:38:23Z-
dc.date.available2014-12-21T16:38:23Z-
dc.date.issued2007-
dc.identifier.issn0090-8258-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/96068-
dc.description.abstractOBJECTIVES: The aim of the study was to assess the expression of the Rb pathway (p16(INK4a)-cdk4-pRb) in cervical intraepithelial neoplasia as a prognostic marker by investigating the association between expression of Rb pathway and the recurrence. METHODS: The study group comprised of 265 paraffin-embedded tissues of the uterine cervix collected from patients between 2001 and 2003. Patients underwent ablative or excisional treatment and were followed for 2 years. RB pathway expression was examined using immunohistochemistry applied to a tissue microarray. HPV detection and genotyping were performed with HPV DNA Chip. Statistical analysis was done by ANOVA test, Student's t test, and Pearson's correlation test. RESULTS: With increasing CIN grade, p16(INK4a) and cdk4 expression rates increased, while the pRb expression rate decreased. The expression rate of p16(INK4a) was higher (33%) in CIN I with high-risk HPV infection than in CIN I without high-risk HPV infection (19%). The mean expression rates of p16(INK4a) were 29%, 39%, and 64%, respectively, in CIN I, II, and III without recurrence, but 25%, 28%, and 44% in those with recurrence. The mean expression rates of pRb were 47%, 40%, and 18% in CIN I, II, and III without recurrence, respectively, but 48%, 45%, and 34% in those with recurrence. CONCLUSION: A relatively low expression rate of p16(INK4a) has prognostic significance for predicting recurrence. The clinical utility of p16(INK4a) status for stratifying patients according to their need for aggressive treatment requires further investigation.-
dc.description.statementOfResponsibilityopen-
dc.format.extent207~211-
dc.relation.isPartOfGYNECOLOGIC ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAlphapapillomavirus/classification-
dc.subject.MESHAlphapapillomavirus/isolation & purification-
dc.subject.MESHCervical Intraepithelial Neoplasia/metabolism*-
dc.subject.MESHCervical Intraepithelial Neoplasia/pathology-
dc.subject.MESHCervical Intraepithelial Neoplasia/virology-
dc.subject.MESHCyclin-Dependent Kinase 4/biosynthesis-
dc.subject.MESHCyclin-Dependent Kinase 4/metabolism-
dc.subject.MESHCyclin-Dependent Kinase Inhibitor p16/biosynthesis-
dc.subject.MESHCyclin-Dependent Kinase Inhibitor p16/metabolism-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHImmunohistochemistry-
dc.subject.MESHPapillomavirus Infections/complications-
dc.subject.MESHPapillomavirus Infections/metabolism-
dc.subject.MESHParaffin Embedding-
dc.subject.MESHPredictive Value of Tests-
dc.subject.MESHPrognosis-
dc.subject.MESHRetinoblastoma Protein/biosynthesis*-
dc.subject.MESHRetinoblastoma Protein/metabolism-
dc.subject.MESHUterine Cervical Neoplasms/metabolism*-
dc.subject.MESHUterine Cervical Neoplasms/pathology-
dc.subject.MESHUterine Cervical Neoplasms/virology-
dc.titleThe expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pathology (병리학)-
dc.contributor.googleauthorEun Ji Nam-
dc.contributor.googleauthorJae Wook Kim-
dc.contributor.googleauthorSunghoon Kim-
dc.contributor.googleauthorNam Hoon Cho-
dc.contributor.googleauthorBo Sung Yoon-
dc.contributor.googleauthorJae Hoon Kim-
dc.contributor.googleauthorYoung Tae Kim-
dc.contributor.googleauthorSang Wun Kim-
dc.identifier.doi10.1016/j.ygyno.2006.07.043-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00595-
dc.contributor.localIdA00866-
dc.contributor.localIdA00526-
dc.contributor.localIdA00729-
dc.contributor.localIdA00876-
dc.contributor.localIdA01262-
dc.contributor.localIdA02554-
dc.contributor.localIdA03812-
dc.relation.journalcodeJ00956-
dc.identifier.eissn1095-6859-
dc.identifier.pmid17046054-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0090825806005865-
dc.contributor.alternativeNameKim, Sang Wun-
dc.contributor.alternativeNameKim, Sung Hoon-
dc.contributor.alternativeNameKim, Young Tae-
dc.contributor.alternativeNameKim, Jae Wook-
dc.contributor.alternativeNameKim, Jae Hoon-
dc.contributor.alternativeNameNam, Eun Ji-
dc.contributor.alternativeNameYoon, Bo Sung-
dc.contributor.alternativeNameCho, Nam Hoon-
dc.contributor.affiliatedAuthorKim, Sung Hoon-
dc.contributor.affiliatedAuthorKim, Jae Wook-
dc.contributor.affiliatedAuthorKim, Sang Wun-
dc.contributor.affiliatedAuthorKim, Young Tae-
dc.contributor.affiliatedAuthorKim, Jae Hoon-
dc.contributor.affiliatedAuthorNam, Eun Ji-
dc.contributor.affiliatedAuthorYoon, Bo Sung-
dc.contributor.affiliatedAuthorCho, Nam Hoon-
dc.rights.accessRightsnot free-
dc.citation.volume104-
dc.citation.number1-
dc.citation.startPage207-
dc.citation.endPage211-
dc.identifier.bibliographicCitationGYNECOLOGIC ONCOLOGY, Vol.104(1) : 207-211, 2007-
dc.identifier.rimsid35408-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.